{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:11:30Z","timestamp":1774343490280,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T00:00:00Z","timestamp":1200614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s10875-007-9168-x","type":"journal-article","created":{"date-parts":[[2008,1,17]],"date-time":"2008-01-17T18:01:36Z","timestamp":1200592896000},"page":"268-275","source":"Crossref","is-referenced-by-count":62,"title":["Inflammation, T-Cell Phenotype, and Inflammatory Cytokines in Chronic Kidney Disease Patients Under Hemodialysis and its Relationship to Resistance to Recombinant Human Erythropoietin Therapy"],"prefix":"10.1007","volume":"28","author":[{"given":"El\u00edsio","family":"Costa","sequence":"first","affiliation":[]},{"given":"Margarida","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Moura","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Petronila","family":"Rocha-Pereira","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Vasco","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"Maria do Sameiro","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Alfredo","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Quintanilha","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Belo","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,1,18]]},"reference":[{"key":"9168_CR1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1440-1797.2006.00701.x","volume":"11","author":"PG Kerr","year":"2006","unstructured":"Kerr PG. Renal anaemia: recent developments, innovative approaches and future directions for improved management. Nephrology. 2006;11:542\u20138.","journal-title":"Nephrology."},{"issue":"suppl 5","key":"9168_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/16.suppl_5.50","volume":"16","author":"IC Macdougall","year":"2001","unstructured":"Macdougall IC. Present and future strategies in the treatment of renal anaemia. Nephrol Dial Transpl. 2001;16(suppl 5):50\u20135.","journal-title":"Nephrol Dial Transpl."},{"issue":"Suppl 11","key":"9168_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","volume":"17","author":"IC Macdougall","year":"2002","unstructured":"Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2002;17(Suppl 11):39\u201343.","journal-title":"Nephrol Dial Transplant."},{"issue":"suppl 3","key":"9168_CR4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis. 1998;32(suppl 3):S112\u20139.","journal-title":"Am J Kidney Dis."},{"key":"9168_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","volume":"28","author":"RN Foley","year":"1996","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy morbidity and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53\u201361.","journal-title":"Am J Kidney Dis."},{"issue":"Suppl 8","key":"9168_CR6","doi-asserted-by":"crossref","first-page":"viii2","DOI":"10.1093\/ndt\/gfh1109","volume":"20","author":"J Smrzova","year":"2005","unstructured":"Smrzova J, Balla J, B\u00e1r\u00e1ny P. Inflammation and resistance to erythropoiesis-stimulting agents\u2014what do we know and what needs to be clarified. Nephrol Dial Transpant. 2005;20(Suppl 8):viii2\u20137.","journal-title":"Nephrol Dial Transpant."},{"key":"9168_CR7","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/01.ASN.0000071514.36428.61","volume":"14","author":"AC Cooper","year":"2003","unstructured":"Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-\u03b3, TNF-\u03b1, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14:1776\u201384.","journal-title":"J Am Soc Nephrol."},{"key":"9168_CR8","first-page":"607","volume":"10","author":"IC Macdougal","year":"1995","unstructured":"Macdougal IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant. 1995;10:607\u201314.","journal-title":"Nephrol Dial Transplant."},{"issue":"suppl 2","key":"9168_CR9","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/ndt\/10.supp2.62","volume":"10","author":"TB Drueke","year":"1995","unstructured":"Drueke TB. R-HuEPO hyporesponsiveness: who and why. Nephrol Dial Transplant. 1995;10(suppl 2):S62\u20138.","journal-title":"Nephrol Dial Transplant."},{"issue":"suppl 2","key":"9168_CR10","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/ndt\/10.supp2.69","volume":"10","author":"B Danielson","year":"1995","unstructured":"Danielson B. R-HuEPO hyporesponsiveness: who and why. Nephol Dial Transplant. 1995;10(suppl 2):S69\u201373.","journal-title":"Nephol Dial Transplant."},{"key":"9168_CR11","first-page":"545","volume":"29","author":"S Fishbane","year":"2000","unstructured":"Fishbane S. Hyporesponsiveness to recombinant human erythropoietin in dialysis patients. Dial Transplant. 2000;29:545\u20138.","journal-title":"Dial Transplant."},{"key":"9168_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ndt\/17.1.17","volume":"17","author":"R Schindler","year":"2002","unstructured":"Schindler R, Senf R, Frei U. Influencing the inflammatory response of haemodialysis patients by cytokine elimination using large-pore membranes. Nephrol Dial Transplant. 2002;17:17\u20139.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","volume":"33","author":"J Gunnell","year":"1999","unstructured":"Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999;33:63\u201372.","journal-title":"Am J Kidney Dis."},{"key":"9168_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ndt\/18.1.133","volume":"18","author":"AC Cooper","year":"2003","unstructured":"Cooper AC, Breen CP, Vyas B, Ochola J, Kemeny DM, Macdougall IC. Poor response to recombinant erythropoitin is associated with loss of T-lymphocyte CD28 expression and altered interleukin-10 production. Nephrol Dial Transplant. 2003;18:133\u201340.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","volume":"154","author":"B Descamps-Latscha","year":"1995","unstructured":"Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, Groote D, Jungers P, Dayer JM. Balance between IL-1\u03b2, TNF-\u03b1, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunology. 1995;154:882\u201392.","journal-title":"J Immunology."},{"key":"9168_CR16","first-page":"204","volume":"24","author":"RT Means Jr","year":"1996","unstructured":"Means RT Jr, Krantz SB. Inhibition of human erythroid colony forming units by interferons \u03b1 and \u03b2: differing mechanisms despite shared receptor. Exp Haematol. 1996;24:204\u20138.","journal-title":"Exp Haematol."},{"key":"9168_CR17","first-page":"204","volume":"47","author":"DA Allen","year":"1999","unstructured":"Allen DA, Breen C, Yaqoob MM, Macdougall IC. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of INF-\u03b3 and TNF-\u03b1. J Invest Med. 1999;47:204\u201311.","journal-title":"J Invest Med."},{"key":"9168_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1681\/ASN.V131204","volume":"13","author":"P Meier","year":"2002","unstructured":"Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephol. 2002;13:204\u201312.","journal-title":"J Am Soc Nephol."},{"key":"9168_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00917139","volume":"4","author":"WC Waltzer","year":"1984","unstructured":"Waltzer WC, Bachvaroff RJ, Raisbeck AP, Egelandsdal B, Pullis C, Shen L, Rapaport FT. Immunological monitoring in patients with end-stage renal disease. J Clin Immunol. 1984;4:364\u20138.","journal-title":"J Clin Immunol."},{"key":"9168_CR20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2005.09.007","volume":"118","author":"NHR Litjens","year":"2006","unstructured":"Litjens NHR, van Druninger CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of na\u00efve T lymphocytes. Clinical Immunology. 2006;118:83\u201391.","journal-title":"Clinical Immunology."},{"issue":"Suppl 2","key":"9168_CR21","first-page":"ii1","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Aljama P, Barany P, European Best Practice Guidelines Working Group, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl 2):ii1\u201347.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.1830240707","volume":"24","author":"AD d\u2019Angeac","year":"1997","unstructured":"d\u2019Angeac AD, Monier S, Pilling D, Travaglio-Encinoza A, Reme T, Salmon M. CD57+ T lymphocytes are derived from CD57-precursors by differentiation occurring in late immune responses. Eur J Immunol. 1997;24:1503\u201311.","journal-title":"Eur J Immunol."},{"key":"9168_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1079-9796(03)00014-7","volume":"30","author":"M Lima","year":"2003","unstructured":"Lima M, Teixeira Mdos A, Queiros ML, Santos AH, Goncalves C, Correia J, Farinha F, Mendonca F, Soares JM, Almeida J, Orfao A, Justica B. Immunophenotype and TCR-Vbeta repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells Mol Dis. 2003;30:1\u201312.","journal-title":"Blood Cells Mol Dis."},{"key":"9168_CR24","first-page":"331","volume":"18","author":"M Lima","year":"2004","unstructured":"Lima M, Almeida J, Teixeira MA, Santos AH, Queiros ML, Fonseca S, Moura J, Goncalves M, Orfao A, Pinto Ribeiro AC. Reactive phenotypes after acute and chronic NK-cell activation. J Biol Regul Homeost Agents. 2004;18:331\u20134.","journal-title":"J Biol Regul Homeost Agents."},{"key":"9168_CR25","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","volume":"178","author":"P Romero","year":"2007","unstructured":"Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol. 2007;178:4112\u20139.","journal-title":"J Immunol."},{"key":"9168_CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ndt\/16.2.224","volume":"16","author":"P B\u00e1r\u00e1ny","year":"2001","unstructured":"B\u00e1r\u00e1ny P. Inflammation, serum C-reactive protein, and erythropoietin resistance. Nephrol Dial Transplant. 2001;16:224\u20137.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/ajkd.2001.29280","volume":"38","author":"MA Spittle","year":"2001","unstructured":"Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001;38:1408\u201313.","journal-title":"Am J Kidney Dis."},{"key":"9168_CR28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ndt\/gfg066","volume":"18","author":"DN Reddan","year":"2003","unstructured":"Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O\u2019Shea S, Owen WF Jr, Lowrie EG. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18:1167\u201373.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ndt\/15.4.502","volume":"15","author":"G Fernandez-Fresnedo","year":"2000","unstructured":"Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, de Francisco AL, Lopez-Hoyos M, Aris M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000;15:502\u201310.","journal-title":"Nephrol Dial Transplant."},{"key":"9168_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.1986.129","volume":"29","author":"P Kurz","year":"1986","unstructured":"Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH. Impaired cellular immune response in chronic renal failure: evidence for a T cell defect. Kidney Int. 1986;29:1209\u201314.","journal-title":"Kidney Int."},{"key":"9168_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2005.09.007","volume":"118","author":"NHR Litjens","year":"2006","unstructured":"Litjens NHR, van Druningen CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of na\u00efve T lymphocytes. Clinical Immunology. 2006;118:83\u201391.","journal-title":"Clinical Immunology."},{"key":"9168_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4049\/jimmunol.173.1.673","volume":"173","author":"I Kang","year":"2004","unstructured":"Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol. 2004;173:673\u201381.","journal-title":"J Immunol."},{"key":"9168_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/83381","volume":"7","author":"LA Napolitano","year":"2001","unstructured":"Napolitano LA, Grant RM, Dreeks SG, Schmidt D, De Rosa SC, Herzenberg LA, Herndier BG, Andersson J, McCune JM. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med. 2001;7:73\u20139.","journal-title":"Nat Med."},{"key":"9168_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0006-291X(03)01389-5","volume":"308","author":"B Moser","year":"2003","unstructured":"Moser B, Roth G, Brunner M, Lilaj T, Deicher R, Wolner E, Kovarik J, Boltz-Nitulescu G, Vychytil A, Ankersmit HJ. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun. 2003;308:581\u20135.","journal-title":"Biochem Biophys Res Commun."},{"key":"9168_CR35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","volume":"16","author":"Q Jiang","year":"2005","unstructured":"Jiang Q, Li WQ, Aiello FB, Mazzucchelli B, Asefa B, Khaled AR, Durum SK. Cell biology of IL-7, a key lymphotrophim. Cytokine Growth Factor Rev. 2005;16:513\u201333.","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-007-9168-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9168-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T10:38:38Z","timestamp":1708511918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-007-9168-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["9168"],"URL":"https:\/\/doi.org\/10.1007\/s10875-007-9168-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,18]]}}}